Newswire (Published: Tuesday, February 28, 2017, Received: Thursday, February 23, 2017, 9:44:02 PM CST)

Word Count: 395

Study Data from Brigham and Women's Hospital Provide New Insights into Prostate Cancer (The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer)

By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Oncology - Prostate Cancer. According to news reporting originating in Boston, Massachusetts, by NewsRx editors, the research stated, "The controversy surrounding the relationship between testosterone and prostate cancer has existed for decades. The literature surrounding this topic is confusing and at times contradictory."

The news reporters obtained a quote from the research from Brigham and Women's Hospital, "There is no level-one quality evidence that confirms or refutes the relationship between either high or low serum testosterone levels and the subsequent development of prostate cancer. This commentary aims to review the issues involved and to provide an interpretation as to the causes of the confusion and to provide a framework for ongoing discussion and investigation. A Medline and PubMed search was conducted using search terms: testosterone levels and prostate cancer to identify pertinent literature. There is no consistent evidence that a single testosterone level is predictive of prostate cancer risk. The development of prostate cancer is a complex biologic process potentially involving genetics,dietary, life style and hormonal factors. Serum testosterone levels do not accurately reflect the internal prostatic milieu."

According to the news reporters, the research concluded: "Finally, if testosterone levels are to be considered in the etiology of prostate cancer they should be measured and interpreted on a chronic basis with multiple measurements over a period of years."

For more information on this research see: The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer. Urologic Oncology-Seminars and Original Investigations, 2016;34(11):199-202. Urologic Oncology-Seminars and Original Investigations can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA (see also Oncology - Prostate Cancer).

Our news correspondents report that additional information may be obtained by contacting K.R. Loughlin, Brigham & Women's Hospital, Div Urol, Boston, MA 02115, United States.

Keywords for this news article include: Boston, Massachusetts, United States, North and Central America, Metastatic Prostate Cancer, Risk and Prevention, Prostatic Neoplasms, Cancer Risk, Oncology, Genetics, Brigham and Women's Hospital.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

The Brigham and Women's Hospital Inc

Places

Central America
North America
Canada
United States
Americas
Quebec
Massachusetts
New York
Brigham
Boston
New York City

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Health Sciences
            Medical Research